Vincent Geskens
20 November 2025
Overcoming Regulatory and Quality concerns for cell and gene therapies
12-hour
Overview of CGT, regulatory process FDA/EMA, BLA/MAA, CTD, regulatory strategy for CGT, clinical trial and IND application for CGT, reviewing quality/CMC challenges for CGT
Andrew Willis

Distributed by:

Issued to

Vincent Geskens

Want to report a typo or a mistake?

Credential Verification

Issue date: November 20, 2025

ID: fdf97ccf-3d23-44dc-806a-573661349453

Educo Life Sciences is a learning and development specialist that provides technical training solutions to the pharmaceutical, biotechnology, cell and gene, and medical device industries. ,

Type

Course

Level

Professional

Format

Hybrid

Duration

12 hours

Price

Paid

Description

The holder of this certificate has attended the course "Overcoming Regulatory and Quality Concerns for Cell and Gene Therapies".

This training course will provide you with a complete understanding of the regulatory and quality requirements for cell and gene therapies in the EU and US. Once completed, you will know the regulatory requirements and quality data required in clinical applications and the Common Technical Document (CTD). With a complete understanding of the regulatory routes to market in the EMA and FDA, you will have the confidence to devise a regulatory strategy for your CGT product.

Skills

Regulatory Requirements

Regulatory Affairs

ATMPs

cell and gene therapies

CMC

Earning Criteria

Participation

Attended the live online or in-person course held by Educo Life Sciences.

Watching

Or watched the recorded materials for the course held by Educo.